NVST Stock Analysis: Buy, Sell, or Hold?
NVST - Envista Holdings Corporation Common stock, $0.01 par value per share
$27.34
0.14 (0.51%)
â˛
5d:
-1.09%
30d:
+3.84%
90d:
+16.69%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Get Alerted When NVST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: NVST is fairly priced but lacks strong directional signals. At -1.2% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: NVST is fairly priced but lacks strong directional signals. At -1.2% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$38.63
Based on 6.4% avg growth
INTRINSIC VALUE TODAY
$23.99
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NVST is currently trading at $27.34, which is considered fair relative to its 30-day fair value range of $26.75 to $28.17. The stock's valuation (Forward PE: 16.4) is in line with its historical norms (17.0). Remarkably, the market is currently pricing in an annual earnings decline of 1.2% over the next few years. This pessimistic expectation contrasts with the company's recent 111.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, NVST is in a strong uptrend. The price is currently testing key support at $26.79. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NVST scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $30.57 (+11.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NVST is in a strong uptrend. The price is currently testing key support at $26.79. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NVST scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $30.57 (+11.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$26.75 -
$28.17
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.6%
Protect Your Profits
Holding NVST? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($30.57)
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$26.75 -
$28.17
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$26.79
Resistance Level
$29.00
Current Trend
Strong Uptrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.40
Wall Street Target
$30.57
(+11.8%)
Revenue Growth (YoY)
7.1%
Earnings Growth (YoY)
111.3%
Profit Margin
3.3%
Valuation Discount vs History
-1.2% cheaper
PE vs Historical
16.4 vs 17.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.2%
(market-implied from PE analysis)
1-Year Target
$27.01
(-1%)
2-Year Target
$26.69
(-2%)
3-Year Target
$26.37
(-4%)
3-Yr Target (if PE normalizes)
(PE: 16â17)
$27.34
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 8.8%)
$43.05
(+58%)
Base:
(SPY PE: 16.4, Growth: 8.8%)
$35.21
(+29%)
Bear:
(PE: 13.9, Growth: 8.8%)
$29.93
(+10%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (47x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 47.25 | Current EPS (TTM): $0.57
Bull Case
$59.25
(+118%)
Analyst growth 100.0%, PE expands to 52.0
Base Case
$53.86
(+98%)
Market implied 100.0%, PE stable at 47.3
Bear Case
$18.31
(-33%)
Severe decline -20.0%, PE contracts to 40.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.4 to 17.0
Stabilization Target:
$28.35
(+3.7%)
PE Expansion Potential:
+3.7%
Share & Embed Analysis
Last updated: August 24, 2026 5:26 PM ET
Data refreshes hourly during market hours. Next update: 6:26 PM
Data refreshes hourly during market hours. Next update: 6:26 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NVST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 37 SELL |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 39 SELL |
|
WST
West Pharmaceutical ServâĻ |
STRONG BUY
13 analysts |
$405 | 58 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 35 SELL |
|
RMD
ResMed Inc |
BUY
19 analysts |
$246 | 45 HOLD |
Advanced NVST Option Strategies
Professional options setups generated by AI based on today's NVST price and gamma walls.
